Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors
- 1 June 1994
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 19 (2), 161-168
- https://doi.org/10.1007/bf01306458
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcomaJournal of Neuro-Oncology, 1993
- Allogeneic tumor-specific cytotoxic T lymphocytesCancer Immunology, Immunotherapy, 1992
- Long-Term Follow-up of Patients with Recurrent Malignant Gliomas Treated with Adjuvant Adoptive ImmunotherapyNeurosurgery, 1991
- Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapyNeurosurgery, 1991
- Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.Proceedings of the National Academy of Sciences, 1990
- Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomasJournal of Neuroimmunology, 1990
- Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytesJournal of Neuro-Oncology, 1990
- Lymphoid Cell-Glioma Cell Interaction Enhances Cell Coat Production by Human Gliomas: Novel Suppressor MechanismScience, 1983
- Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human GliomasJournal of Neuropathology and Experimental Neurology, 1981